ENSCEnsysce Biosciences, Inc. · NASDAQ Capital Market · $0.46 · $8.91M mkt cap
Assessed Aug 29, 2026 · Reassessment
Is the float you're seeing correct?
18.29M
Estimated float

Outstanding (19,456,794 per 10-Q cover 2026-08-12) less the only documented insider block (Gower 916,740, which already includes his 508,614 unregistered conversion shares) less the unregistered half of Galephar milestone shares (234,375).

Confirmed · within 1%
18.54M
Reported float

Data-service feed, fetched today. The number TradingView and most screeners show.

Your screener's float is right for ENSC. Trade off 18.29M shares. What it does not show you is what is about to be added to it.

Dilution risk9/10EXTREME
CONFIDENCE: MEDIUM

The float your screener shows is right, at 18.29M. 3 convertible notes and 3 reverse splits can add another 732% of the float.

  • Preferred stock conversion overhang. Series C Preferred Stock created in August 2026 represents up to 129,614,000 common shares — 708% of the 18.3M tradeable float and 666% of the 19.5M shares outstanding.

  • Rapid share count growth. Shares outstanding grew from 2,968,444 on 2025-08-12 to 19,456,794 on 2026-08-12 — a 555% increase in twelve months, entirely post-reverse-split.

  • Variable-rate convertible / death-spiral mechanics (recently extinguished). The Series B Preferred sold to 3i, LP carried textbook floating-price terms: holder-elected conversion at 95% of the lowest VWAP over the preceding five trading days (90% following a triggering event…

From today's float to the ceiling

shares
18.29M
Estimated float
tradeable today
+1.30M can sell now
19.59M
Effective supply
float plus what sells on notice
+134.55M if floors are cut and warrants exercise
154.14M
Fully diluted
ceiling

Where the shares come from

each subtotal is a rung on the ladder above

Tradeable today
18.29M
Can sell now
Registered resale shares, issuable on notice
Already effective; the holder can sell without a further filing.
+1.30M
Warrants in the money
None of the outstanding warrants are exercisable at this price.
+0
Effective supply
19.59M
Converts only if floors are cut
Notes with no conversion price set
Sized in dollars until a price or floor is set; not counted in the ceiling.
$14.00M
Preferred stock, as converted
Common equivalent at the stated conversion ratio.
+129.61M
Above the current price
Warrants out of the money
Struck above the current tape; supply only if the stock rises.
+11.65M
Options and RSUs
Employee equity; vests and settles over time.
+93.3K
Fully diluted
154.14M

Not counted anywhere: ATM and shelf capacity. Convertible share counts use stated conversion prices.

See the full breakdown

Red flags, financing counterparties, the deal timeline, and every SEC filing — free with an account.

Sign in to continue

The facts

Price
$0.46
Market cap
$8.91M
Shares outstanding
19.46M
Reported float
18.54M
Avg volume
620.5K
Reverse splits
3 · latest 1-for-15 · Dec 6, 2024
Going concern
Yes · 10 quarters runway
Quarterly burn
$3.00M

Market data as of Sep 19, 2026

Key dates

  • Oct 26, 2026 · One half of the April 2025 Common Warrants at $1.90 expire (part of the 134,314-share remaining block)